Get started
Author

Abrar Saleh Alharbi

Observed names: Abrar AlHarbi, Abrar S. Alharbi, Abrar Salman Alharbi
ORCID: 0000-0002-1578-9513
Observed ORCID: 0000-0002-1578-9513
OpenAlex ID: A5005355709
A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox Outbreak
2022 · Mazen Almehmadi, Mamdouh Allahyani, et al. · Viruses · 55
PDF
An insight into the discovery, clinical studies, compositions, and patents of macozinone: A drug targeting the DprE1 enzyme of Mycobacterium tuberculosis
2022 · Mohd. Imran, Shah Alam Khan, et al. · Journal of Infection and Public Health · 33
PDF
Nanoplatform for the Delivery of Topotecan in the Cancer Milieu: An Appraisal of its Therapeutic Efficacy
2022 · Mohammed Kanan Alshammari, Mohammed Khalid Alghazwni, et al. · Cancers · 19
PDF
Cancer theranostics employing microneedles: Experimental and patented strategies
2023 · Mohammed Kanan Alshammari, Bashayr Naji A. Albutayh, et al. · Journal of Drug Delivery Science and Technology · 17
Point prevalence survey of antibiotics use among hospitalised neonates and children in Saudi Arabia: findings and implications
2024 · Hind M. Alosaimi, Mohammed K. Alshammari, et al. · Journal of Pharmaceutical Policy and Practice · 4
Accuracy of diagnostic modalities in suspected appendicitis in King Saud Hospital, Unaizah,Qassim, Saudi Arabia-retrospective cohort study
2022 · Moath AlJohani, Lamees AlSulaim, et al. · International Journal of Surgery Open · 3
PDF
Indication, Contraindication, Complication and Monitoring of Isotretinoin
2022 · Nawal Rajeh Alyamani, Abrar Saleh Alharbi, et al. · Journal of Pharmaceutical Research International · 1
Effectiveness and safety of bronchodilators and inhaled corticosteroids in the management of chronic obstructive pulmonary disease
2023 · Mona Saleh Shalabi, Sameerah Waheed Aqdi, et al. · International Journal of Community Medicine and Public Health
PDF
Works count: 8
Citation count: 132
H-index: 4
I10-index: 4
Year
Topic
Type